| Home Market Dynamics Sector Analysis Company Insights AI Investing Strategies Contact Us Login |
| Thermo Fisher Scientific is enhancing its role in the life sciences industry through significant investments aimed at fostering innovation and manufacturing within the biopharma sector. Their advancements in biologic therapeutics, including the development of new technologies and cell lines, are set to improve the production and efficiency of biologic therapies. This strategic focus reflects a commitment to supporting the evolving needs of biopharma companies. Overall, the company's initiatives position it as a key player in the future of product and service development in life sciences. |
| The price action of Thermo Fisher Scientific (TMO) is impacted by broad market risk appetite, sector price trend, company-specific performance and market structure. The market sentiment at 0.4 is modestly bullish. Trend sentiment measures the current trend of the stock price, and market sentiment reflects what market participants collectively think where the price will move next.There is no clear direction for TMO since trend sentiment and market sentiment are at the opposite directions. The positive sentiment force for sector is at 0.6, and the negative at -0.2 on 2025-04-28. The forces of and Valuation Sentiment (-1) will drive down the price. The forces of Stock Price Trend (0), Sector Price Trend (0), Price Level Sentiment (0), Option Sentiment (0), Market Risk Appetite (0), and Sentiment towards Fundamentals (3.6) will drive up the price. The sentiment for Sector Price Trend is calculated based on the price trend of related sector ETF. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Appetite is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. The price level reaches 100 at Bollinger upper band, and zero at lower band. |
| TMO | |||||||||||||
| Date | Attention | Price | Price Level | Change | SMA10 Trend | Trend Sentiment | Hourly Trend | Hourly StdDev | Market Sentiment | Action | P | Fund. | News Sentiment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-04-28 | 0%(0%) | 0 | 0% | 0.4 | 3.6 | -1 | |||||||
| 2025-04-27 | 0%(0%) | 0 | 0% | 0.6 | 4.3 | -1 | |||||||
| 2025-04-26 | 0%(0%) | 0 | 0% | 0.6 | 4.3 | -1 | |||||||
| 2025-04-25 | 0%(0%) | 0 | 0% | 0.6 | 4.3 | -1 | |||||||
| 2025-04-24 | 0%(0%) | 0 | 0% | 0.6 | 4.3 | -1 | |||||||
| 2025-04-23 | 0%(0%) | 0 | 0% | 0.6 | 4.3 | -1 | |||||||
| 2025-04-22 | 0%(0%) | 0 | 0% | 0.3 | 2.8 | -1 | |||||||
| 2025-04-21 | 0%(0%) | 0 | 0% | 0.3 | 2.8 | -1 | |||||||
| 2025-04-20 | 0%(0%) | 0 | 0% | 0.4 | 3.2 | -1 | |||||||
| 2025-04-19 | 0%(0%) | 0 | 0% | 0.3 | 3 | -1 | |||||||
| Wait action is recommended in three scenarios with either high uncertainty or high risk: 1. The trend sentiment and market sentiment are at the opposite directions. 2. Both trend sentiment and market sentiment are positive, but the price level is elevated. 3. Both trend sentiment and market sentiment are negative, but the price level is depressed. In an uptrend, as an investor, you may want to wait for the pullback to open long position. In a downtrend, the price will likely rebound after huge decline. As an investor, you may want to wait for the rebound to exit long position. | |||||||||||||
| Market sentiment will accelerate the current trend when both trend sentiment and market sentiment are at the same direction. Market sentiment will generate volatility when it's at the opposite direction of the trend sentiment. News sentiment measures the daily emotion of the market. News sentiment may impact the daily price change while market sentiment is a more stable and consistent moving force. | |||||||||||||
| 2025-07-18 18:32:52 The impact of improved technologies on the efficiency of regulatory processes for new drug approvals. |
| 2025-07-18 18:32:52 The ability of new cell lines to produce higher yields of proteins for therapeutic use, providing a competitive edge. |
| 2025-07-18 18:32:52 Logistical complexities faced by biotech and pharmaceutical companies during pre-clinical drug development phases. |
| 2025-07-18 18:32:52 Innovations that significantly shorten the time frames required for drug development and regulatory approval. |
| 2025-07-18 18:32:52 The development of new technologies and cell lines to enhance the production and efficiency of biologic therapies. |